Skip to main content
. 2017 Dec 27;9(5):6201–6212. doi: 10.18632/oncotarget.23717

Table 2. Basic demographic data of 103 evaluable TNBC cases (BCT = breast conserving therapy).

Clinico-pathological parameter (n) (%)
Tumor stage
 I 24 23.3
 II 52 50.4
 III 12 11.7
 IV 7 6.8
 unknown 8 7.8
Histologic subtype
 invasive ductal 90 87.3
 invasive lobular 0 0
 medullary 12 11.7
 mucinous 1 1
Grading
 1 1 1
 2 19 18.4
 3 77 74.8
 unknown 6 5.8
Mean age at diagnosis: 53.4y
 premenopausal 43 41.7
 postmenopausal 54 52.4
 unknown 6 5.8
Surgery
 mastectomie 41 39.8
 BCT 62 60.2
Radiation
 yes 70 68
 no 29 28.2
 unknown 4 3.8
Chemotherapy
 a: yes 84 81.6
 b: adjuvant 76 90.5 (of a)
 c: neoadjuvant 8 9.5 (of b)
 d: no 11 10.7
 e: unknown 8 7.8